Skip to main content

Table 1 Characteristics and outcomes of hospital discharges after percutaneous coronary intervention among patients with and without type 2 diabetes in Spain, 2001–2011

From: National trends in utilization and outcomes of coronary revascularization procedures among people with and without type 2 diabetes in Spain (2001–2011)

  

2001

2002

2003

2004

2005

2006

2007

2008

2009

2010

2011

No diabetes

N

16200

18842

21438

24375

27745

29184

31607

33452

34840

34463

35186

Incidence*

71.3

82.1

91.4

101.8

113.5

116.8

123.8

128.4

131.4

128.2

128.9

Age§, mean

62.9

63.0

62.8

63.3

63.7

63.9

64.1

64.3

64.4

64.3

64.5

(SD)

(11.4)

(11.6)

(11.7)

(11.7)

(11.8)

(11.9)

(12.0)

(12.2)

(12.3)

(12.4)

(12.5)

Female ǂ, n

3039

3526

3971

4771

5542

5866

6353

6820

7199

7097

7389

(%)

(18.7)

(18.7)

(18.5)

(19.5)

(19.9)

(20.1)

(20.1)

(20.3)

(20.6)

(20.5)

(21)

CCI 0ǂ, n

12541

14250

16116

18102

20564

21687

22987

24070

24771

24362

24683

(%)

(77.4)

(75.6)

(75.1)

(74.2)

(74.1)

(74.3)

(72.7)

(71.9)

(71.1)

(70.6)

(70.1)

CCI 1-2ǂ, n

3561

4473

5152

6057

6928

7204

8265

8937

9574

9538

9948

(%)

(21.9)

(23.7)

(24.0)

(24.8)

(24.9)

(24.6)

(26.1)

(26.7)

(27.4)

(27.6)

(28.2)

CCI ≥ 3ǂ, n

98

119

170

216

253

293

355

445

495

563

55

(%)

(0.6)

(0.6)

(0.7)

(0.8)

(0.9)

(1.0)

(1.1)

(1.3)

(1.4)

(1.6)

(1.5)

LOS§, median

6.0

6.0

6.0

6.0

6.0

6.0

5.0

5.0

5.0

5.0

5.0

(IQR)

(9.0)

(8.0)

(8.0)

(8.0)

(7.0)

(7.0)

(7.0)

(7.0)

(6.0)

(6.0)

(6.0)

IHM ǂ, n

317

310

400

458

522

510

591

691

782

746

828

(%)

(1.9)

(1.6)

(1.8)

(1.8)

(1.8)

(1.7)

(1.8)

(2.0)

(2.2)

(2.1)

(2.3)

Type 2 diabetes

N

4369

5847

7675

9188

11235

12276

13607

14662

15652

15807

16458

Incidence*

18.8

24.9

32.1

37.7

45.3

48.5

52.8

55.8

58.8

58.6

60.3

Age§, mean

66.1

66.5

66.5

66.8

67.0

67.4

67.7

67.9

67.8

68.2

68.2

(SD)

(9.7)

(9.7)

(9.7)

(9.8)

(9.9)

(9.9)

(10.1)

(10.2)

(10.3)

(10.4)

(10.4)

Female ǂ, n

1440

1937

2463

2852

3454

3853

4255

4577

4618

4579

4723

(%)

(32.9)

(33.1)

(32.0)

(31.0)

(30.7)

(31.3)

(31.2)

(31.2)

(29.5)

(28.9)

(28.7)

CCI 0ǂ, n

3034

3962

5040

5971

7266

8152

8586

8871

9405

9443

9691

(%)

(69.4)

(67.7)

(65.6)

(64.9)

(64.6)

(66.4)

(63.1)

(60.5)

(60.0)

(59.7)

(58.8)

CCI 1-2ǂ, n

1284

1805

2514

3067

3755

3916

4745

5428

5846

5915

6308

(%)

(29.3)

(30.8)

(32.7)

(33.3)

(33.4)

(31.9)

(34.8)

(37.0)

(37.3)

(37.4)

(38.3)

CCI ≥ 3ǂ, n

51

80

121

150

214

208

276

363

401

449

459

(%)

(1.1)

(1.3)

(1.5)

(1.6)

(1.9)

(1.6)

(2.0)

(2.4)

(2.5)

(2.8)

(2.7)

LOS§, median

7.0

7.0

7.0

7.0

7.0

6.0

6.0

6.0

6.0

6.0

6.0

(IQR)

(10.0)

(10.0)

(9.0)

(9.0)

(8.0)

(8.0)

(7.0)

(7.0)

(7.0)

(7.0)

(6.0)

IHM ǂ, n

85

157

186

201

289

314

332

403

405

419

425

 

(%)

(1.9)

(2.6)

(2.4)

(2.1)

(2.5)

(2.5)

(2.4)

(2.7)

(2.5)

(2.6)

(2.5)

  1. N: Number of procedures; LOS: length of stay; IHM: In-hospital mortality;
  2. CCI (Charlson Comorbidity Index): Comorbidities included in the Charlson comorbidity index, except diabetes and AMI.
  3. Incidence per 100.000. Incidence was calculated using the Spanish National Statistics Institute census projections adjusted by sex and age (16).
  4. *P < 0.05 (Poisson regression analysis).
  5. §P < 0.05 (ANOVA or Kruskal-Wallis analysis).
  6. ǂP < 0.05(χ2 linear tend analysis).